Marshall Wace North America’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-431,862
| Closed | -$5.86M | – | 1182 |
|
|
2020
Q2 | $5.86M | Buy |
+431,862
| New | +$5.86M | 0.04% | 349 |
|
|
2019
Q1 | – | Sell |
-22,477
| Closed | -$124K | – | 1524 |
|
|
2018
Q4 | $124K | Sell |
22,477
-558,072
| -96% | -$3.08M | ﹤0.01% | 1042 |
|
|
2018
Q3 | $5.13M | Hold |
580,549
| – | – | 0.04% | 313 |
|
|
2018
Q2 | $5.79M | Sell |
580,549
-17,738
| -3% | -$177K | 0.03% | 474 |
|
|
2018
Q1 | $5.7M | Sell |
598,287
-5,527
| -0.9% | -$52.7K | 0.03% | 540 |
|
|
2017
Q4 | $8.98M | Buy |
603,814
+114,913
| +24% | +$1.71M | 0.05% | 408 |
|
|
2017
Q3 | $9.78M | Buy |
488,901
+99,131
| +25% | +$1.98M | 0.06% | 367 |
|
|
2017
Q2 | $5.46M | Sell |
389,770
-302,726
| -44% | -$4.24M | 0.04% | 474 |
|
|
2017
Q1 | $6.23M | Buy |
+692,496
| New | +$6.23M | 0.05% | 349 |
|